Lidocaine Versus Magnesium Sulphate in Management of Myofascial Pain Dysfunction Syndrome

Inclusion Criteria: * Age Limitations: Participants must be between 18 and 55 years old. * Chronic Pain Diagnosis: Individuals must have a diagnosis of chronic myofascial pain dysfunction syndrome (MPDS) affecting the face muscles, neck, shoulder, or upper back for a duration exceeding three months. * Trigger Point Recognition: Patients must show awareness of their pain when pressure is applied to identified myofascial trigger points, in accordance with established diagnostic guidelines. * Consent to Participate: Willingness to provide informed consent and engage in all aspects of the study. Exclusion Criteria: * Previous Treatments: A history of receiving dry needling or pulsed radiofrequency therapy, or currently participating in other pain management treatments. * Recent Injury or Surgery: Any recent trauma, surgical procedures, or infections in the affected area within the past six months. * Medication Interference: Current or recent use of moderate to strong analgesics (e.g., tramadol, morphine) that could influence pain assessment. * Severe Health Conditions: Individuals with significant systemic illnesses (e.g., severe liver or kidney disease), blood clotting disorders, rheumatoid arthritis or epilepsy. * Mental Health: Presence of current psychiatric disorders, cognitive impairments, or inability to comply with the study protocol.